Postnatal weight gain in preterm infants with severe bronchopulmonary dysplasia

Girija Natarajan1, Yvette R Johnson2, Beverly Brozanski3

  • 1Department of Pediatrics, Wayne State University, Children's Hospital of Michigan, Detroit, Michigan.

Insights

Postnatal growth failure (PGF) is common in preterm infants with severe bronchopulmonary dysplasia (sBPD), worsening throughout hospitalization. Small for gestational age (SGA) infants with sBPD face higher risks of adverse outcomes.

Area of Science:

  • Neonatology
  • Pediatric Critical Care
  • Growth and Development

Background:

  • Severe bronchopulmonary dysplasia (sBPD) is a significant complication in preterm infants.
  • Postnatal growth failure (PGF) is defined as weight below the 10th percentile for postmenstrual age (PMA).
  • Understanding growth patterns in infants with sBPD is crucial for optimizing care.

Purpose of the Study:

  • To characterize PGF in preterm infants (≤ 27 weeks' gestation) with sBPD.
  • To analyze PGF rates at various postmenstrual ages during hospitalization.
  • To compare PGF and small for gestational age (SGA) status in infants who died or underwent tracheostomy versus others.

Main Methods:

  • Retrospective data review from the multicenter Children's Hospital Neonatal Database (CHND).
  • Analysis of a cohort of 375 preterm infants with sBPD.
  • Assessment of PGF at admission and at 36, 40, 44, and 48 weeks' PMA.

Main Results:

  • PGF rates increased progressively from 33% at admission to 79% by 48 weeks' PMA.
  • At discharge, 50% of infants experienced PGF, and 34% required tube feedings.
  • Infants who died or underwent tracheostomy had a significantly higher proportion of SGA (38% vs. 17%; p < 0.01).

Conclusions:

  • Infants with sBPD frequently exhibit progressive PGF during NICU stays.
  • Fetal growth restriction (SGA) may indicate a higher risk of adverse outcomes in infants with sBPD.
  • Early identification and management of PGF are essential for improving outcomes in this vulnerable population.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...